Assyro AI

Orange Book product · Generic (ANDA)

BUMETANIDE

BUMETANIDE

Generic (ANDA)ANDA 074613DISCN TEVA PARENTERAL
View BUMETANIDE familyOpen on FDA Orange Book

At a glance

Nov 18, 1997

Approved

Generic (ANDA)

Application

Not listed

TE code

None

Listed patents

Key dates

  1. Approval

    FDA approval date of this drug product.

    Nov 18, 1997

    29 yr ago

  2. Today

Pharmaceutical detail

Active ingredient

BUMETANIDE

Strength

0.25MG/ML

Dosage form

INJECTABLE

Route

INJECTION

TE code

Not listed

Application

ANDA 074613

Product number

001

Marketing status

DISCN

Reference listed drug (RLD)

No

Reference standard (RS)

No

Active-ingredient family

View full family

Generic (ANDA) of BUMETANIDE

Listed patents

No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.

Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.

Book a Demo